Wei Kang

Targets

• BRAF 1

Filled chips are declared by the researcher; the others come from publications (number of works).

Now

Trials, publications and grants since Nov 2024.

• Publication

  YTHDF1 targets the chemotherapy response by suppressing NOTCH1-induced stemness in colorectal cancer.

  Signal transduction and targeted therapy, Dec 2025

• Publication

  Targeting of the m6A eraser ALKBH5 suppresses stemness and chemoresistance of colorectal cancer.

  Nature communications, Dec 2025

• Publication

  Noninvasive Therapeutic Monitoring of Circulating Tumor DNA in BRAF-Mutant Metastatic Colon Cancer Using Droplet Digital PCR, Next-Generation Sequencing, and Fragmentomics.

  Case reports in oncological medicine, Nov 2025

• Publication

  Spatial and functional dissection of cancer-associated fibroblasts-mediated immune modulation in H. pylori-associated gastric cancer.

  Molecular cancer, Nov 2025

Affiliations

• Chinese University of Hong Kong
• State Key Laboratory of Oncology in South China

Co-authors

• CWChi Chun WongHow are we linked?
• JYJun YuHow are we linked?

Who links you

Enter another researcher's profile link or ID to see who has published with both of you.